Articles published by Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings Provides Corporate Update

March 27, 2024

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Tickers CELZ

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

March 07, 2024

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Tickers CELZ

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

March 06, 2024

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Tickers CELZ

Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201

March 07, 2023

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Tickers CELZ

Three Year Follow-Up Results Confirm Efficacy of StemSpine® Procedure for Treating Chronic Lower Back Pain, with No Serious Adverse Effects

February 14, 2023

From Creative Medical Technology Holdings, Inc.

Via Business Wire

Tickers CELZ

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.